Anebulo Pharmaceuticals (ANEB) Short Interest Ratio & Short Volume → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free ANEB Stock Alerts $2.70 -0.09 (-3.23%) (As of 04:10 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Anebulo Pharmaceuticals Short Interest DataCurrent Short Volume20,100 sharesPrevious Short Volume18,800 sharesChange Vs. Previous Month+6.91%Dollar Volume Sold Short$59,496.00Short Interest Ratio / Days to Cover3.6Last Record DateApril 15, 2024Outstanding Shares25,630,000 sharesFloat Size9,280,000 sharesShort Percent of Float0.22%Today's Trading Volume297 sharesAverage Trading Volume5,315 sharesToday's Volume Vs. Average6% Short Selling Anebulo Pharmaceuticals ? Sign up to receive the latest short interest report for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANEB Short Interest Over TimeANEB Days to Cover Over TimeANEB Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. Anebulo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202420,100 shares $59,496.00 +6.9%0.2%3.6 $2.96 3/31/202418,800 shares $53,956.00 +308.7%0.2%3.4 $2.87 3/15/20244,600 shares $11,684.00 +39.4%0.1%0.5 $2.54 2/29/20243,300 shares $8,976.00 +10.0%0.0%0.4 $2.72 2/15/20243,000 shares $8,250.00 +11.1%0.0%0.3 $2.75 1/31/20242,700 shares $6,952.50 -18.2%0.1%0.2 $2.58 Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,300 shares $7,953.00 -10.8%0.2%0.2 $2.41 12/31/20233,700 shares $8,954.00 -14.0%0.2%0.2 $2.42 12/15/20234,300 shares $8,428.00 +30.3%0.2%0.2 $1.96 11/30/20233,300 shares $7,524.00 +32.0%0.2%0.2 $2.28 11/15/20232,500 shares $5,575.00 -56.1%0.1%0.1 $2.23 10/31/20235,700 shares $12,540.00 -52.5%0.3%0.4 $2.20 10/15/202312,000 shares $29,521.20 +55.8%0.4%0.9 $2.46 9/30/20237,700 shares $23,523.50 -44.6%0.3%1.2 $3.06 9/15/202313,900 shares $44,480.00 +1,444.4%0.5%2.2 $3.20 8/31/2023900 shares $2,511.00 -35.7%0.0%0.1 $2.79 8/15/20231,400 shares $4,074.00 -41.7%0.1%0.3 $2.91 7/31/20232,400 shares $5,184.00 -7.7%0.1%0.7 $2.16 7/15/20232,600 shares $6,526.00 +271.4%0.1%0.9 $2.51 6/30/2023700 shares $1,645.00 +40.0%0.0%0.2 $2.35 6/15/2023500 shares $1,125.00 +25.0%0.0%0.1 $2.25 5/31/2023400 shares $904.00 -91.7%0.0%0.1 $2.26 5/15/20234,800 shares $11,160.00 -18.6%0.1%1.4 $2.33 4/30/20235,900 shares $17,228.00 -9.2%0.1%1.6 $2.92 4/15/20236,500 shares $18,135.65 -22.6%0.1%1.4 $2.79 3/31/20238,400 shares $24,360.00 +460.0%0.2%1.6 $2.90 3/15/20231,500 shares $3,765.00 -94.0%0.0%0.3 $2.51 2/28/202324,900 shares $76,692.00 +6.4%0.5%4.3 $3.08 2/15/202323,400 shares $71,634.42 -19.9%0.5%3.6 $3.06 1/31/202329,200 shares $74,460.00 -24.4%0.6%3.8 $2.55 1/15/202338,600 shares $122,744.14 +0.3%0.8%5.4 $3.18 12/30/202238,500 shares $93,312.45 +1.3%0.8%5.1 $2.42 12/15/202238,000 shares $104,880.00 +49.6%0.8%4.5 $2.76 11/30/202225,400 shares $55,880.00 -5.6%0.6%3.3 $2.20 11/15/202226,900 shares $67,788.00 -9.4%0.6%4.1 $2.52 10/31/202229,700 shares $71,577.00 +29.7%1.3%3.1 $2.41 10/15/202222,900 shares $61,830.00 +9.1%1.0%2.3 $2.70 9/30/202221,000 shares $58,800.00 +78.0%0.9%2.1 $2.80 9/15/202211,800 shares $44,958.00 +35.6%0.5%0.6 $3.81 8/31/20228,700 shares $30,189.00 -71.7%0.4%0.5 $3.47Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. ANEB Short Interest - Frequently Asked Questions What is Anebulo Pharmaceuticals' current short interest? Short interest is the volume of Anebulo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 20,100 shares of ANEB short. 0.22% of Anebulo Pharmaceuticals' shares are currently sold short. Learn More on Anebulo Pharmaceuticals' current short interest. What is a good short interest ratio for Anebulo Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANEB shares currently have a short interest ratio of 4.0. Learn More on Anebulo Pharmaceuticals's short interest ratio. What is a good short interest percentage for Anebulo Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Anebulo Pharmaceuticals' floating shares are currently sold short. Is Anebulo Pharmaceuticals' short interest increasing or decreasing? Anebulo Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 20,100 shares, an increase of 6.9% from the previous total of 18,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Anebulo Pharmaceuticals' float size? Anebulo Pharmaceuticals currently has issued a total of 25,630,000 shares. Some of Anebulo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anebulo Pharmaceuticals currently has a public float of 9,280,000 shares. How does Anebulo Pharmaceuticals' short interest compare to its competitors? 0.22% of Anebulo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Anebulo Pharmaceuticals: Landos Biopharma, Inc. (0.03%), Journey Medical Co. (3.54%), Carisma Therapeutics, Inc. (8.53%), Assembly Biosciences, Inc. (0.84%), Cue Biopharma, Inc. (9.83%), Rallybio Co. (17.17%), vTv Therapeutics Inc. (3.44%), MediciNova, Inc. (0.53%), Corvus Pharmaceuticals, Inc. (3.71%), YS Biopharma Co., Ltd. (0.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Anebulo Pharmaceuticals stock? Short selling ANEB is an investing strategy that aims to generate trading profit from Anebulo Pharmaceuticals as its price is falling. ANEB shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anebulo Pharmaceuticals? A short squeeze for Anebulo Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANEB, which in turn drives the price of the stock up even further. How often is Anebulo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANEB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LABP Short Interest Data DERM Short Interest Data CARM Short Interest Data ASMB Short Interest Data CUE Short Interest Data RLYB Short Interest Data VTVT Short Interest Data MNOV Short Interest Data CRVS Short Interest Data YS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANEB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold